CRF development from the standpoint of clinical data managementBU Qing-yan, XIONG Ning-ning, ZOU Jian-dong, JIANG Meng, LIU Fang339-343
Inhibition of HIV-1 protease in vitro with escins and ursolic acid derivativesYANG Xiu-wei, ZHAO Jing, MA Chao-mei, HATTORI Masao366-369
Toxicity assessments of anti-HIV drug candidates DCK derivativesLIU Mi-feng, PENG Shuang-qing, CHEN Xian-hong, LIU Kun, XIE Lan, GUO Jia-bin, WANG Yi-mei, YANG Hai-ying, YAN Chang-hui, WANG Guo-qiang370-373
Inhibition of Coxsackie virus B3 with aqueous extracts from Spatholobus suberectus in vitroGUO Jin-peng, PANG Ji, WANG Xin-wei, SHEN Zhi-qiang, JIN Min, LI Jun-wen374-377
Modulation of the proliferation of mouse spleen lymphocytes by 3,19-ketal andrographolide derivativesDAI Gui-fu, XU Hai-wei, WANG Jun-feng, LI Qi-ke, WANG Fang, XU Man, LIU Hong-min378-381
Dissolution in vitro and pharmacokinetics of levofloxacin hydrochloride sustained-release tabletsLI Wen-ping, YIN Li-fang, ZHAO Cun-jie, JIANG Zhen-zhou, ZHANG Lu-yong, CHEN Mao, YE Fang, FANG Yu-xin381-385